Trial Outcomes & Findings for Even-Up to Minimize Secondary Site Pain For Ankle Fracture (NCT NCT04164563)

NCT ID: NCT04164563

Last Updated: 2022-10-18

Results Overview

Visual Analog Scale (0 - 100) to assess pain at various musculoskeletal sites. Patients are presented with a slider on a scale to indicate the degree to which they are experiencing pain on a scale from "No Pain" at the far left to "Worst Pain" at the far right. The position on the scale is then translated into a number from 0 (no pain) to 100 (worst pain).

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

6 participants

Primary outcome timeframe

0-24 weeks

Results posted on

2022-10-18

Participant Flow

Participant milestones

Participant milestones
Measure
Group I: CAM Walker Boot
Patients in Group I were assigned to receive a course of CAM walker boot treatment for a period of six weeks.
Group II: CAM+EVENup Orthotic Shoe Lift
Patients in Group II were assigned to receive a course of CAM walker boot treatment with an EVENup orthotic shoe lift to be worn on the contralateral foot for a period of six weeks.
Overall Study
STARTED
3
3
Overall Study
COMPLETED
3
3
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Even-Up to Minimize Secondary Site Pain For Ankle Fracture

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Group I: CAM Walker Boot
n=3 Participants
Patients in Group I were assigned to receive a course of CAM walker boot treatment for a period of six weeks.
Group II: CAM+EVENup Orthotic Shoe Lift
n=3 Participants
Patients in Group II were assigned to receive a course of CAM walker boot treatment with an EVENup orthotic shoe lift to be worn on the contralateral foot for a period of six weeks.
Total
n=6 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
3 Participants
n=5 Participants
3 Participants
n=7 Participants
6 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Continuous
36 years
STANDARD_DEVIATION 17.1 • n=5 Participants
48 years
STANDARD_DEVIATION 21.9 • n=7 Participants
42 years
STANDARD_DEVIATION 18.8 • n=5 Participants
Sex: Female, Male
Female
1 Participants
n=5 Participants
2 Participants
n=7 Participants
3 Participants
n=5 Participants
Sex: Female, Male
Male
2 Participants
n=5 Participants
1 Participants
n=7 Participants
3 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
3 Participants
n=5 Participants
3 Participants
n=7 Participants
6 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
White
2 Participants
n=5 Participants
3 Participants
n=7 Participants
5 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Region of Enrollment
United States
3 participants
n=5 Participants
3 participants
n=7 Participants
6 participants
n=5 Participants
FAAM (0 - 100)
33.7 units on a scale
STANDARD_DEVIATION 14.1 • n=5 Participants
46.8 units on a scale
STANDARD_DEVIATION 24.2 • n=7 Participants
40.3 units on a scale
STANDARD_DEVIATION 19.1 • n=5 Participants

PRIMARY outcome

Timeframe: 0-24 weeks

Visual Analog Scale (0 - 100) to assess pain at various musculoskeletal sites. Patients are presented with a slider on a scale to indicate the degree to which they are experiencing pain on a scale from "No Pain" at the far left to "Worst Pain" at the far right. The position on the scale is then translated into a number from 0 (no pain) to 100 (worst pain).

Outcome measures

Outcome measures
Measure
Group I
n=3 Participants
Patients in Group I were assigned to receive a course of CAM walker boot treatment for a period of six weeks.
Group II
n=3 Participants
Patients in Group II were assigned to receive a course of CAM walker boot treatment with an EVENup orthotic shoe lift to be worn on the contralateral foot for a period of six weeks.
Patient Reported Pain (VAS)
0 weeks - Right Knee
2 score on a scale
Standard Deviation 3.5
0 score on a scale
Standard Deviation 0
Patient Reported Pain (VAS)
6 weeks - Left Knee
0 score on a scale
Standard Deviation 0
16.7 score on a scale
Standard Deviation 28.9
Patient Reported Pain (VAS)
0 weeks - Lower Back
0 score on a scale
Standard Deviation 0
0 score on a scale
Standard Deviation 0
Patient Reported Pain (VAS)
0 weeks - Right Hip
0 score on a scale
Standard Deviation 0
0 score on a scale
Standard Deviation 0
Patient Reported Pain (VAS)
0 weeks - Left Hip
11 score on a scale
Standard Deviation 19.1
0 score on a scale
Standard Deviation 0
Patient Reported Pain (VAS)
0 weeks - Left Knee
0 score on a scale
Standard Deviation 0
0 score on a scale
Standard Deviation 0
Patient Reported Pain (VAS)
0 weeks - Right Ankle
12.7 score on a scale
Standard Deviation 21.9
29.7 score on a scale
Standard Deviation 30.5
Patient Reported Pain (VAS)
0 weeks - Left Ankle
15.7 score on a scale
Standard Deviation 27.1
0 score on a scale
Standard Deviation 0
Patient Reported Pain (VAS)
0 weeks - Right Foot
0 score on a scale
Standard Deviation 0
26.7 score on a scale
Standard Deviation 46.2
Patient Reported Pain (VAS)
0 weeks - Left Foot
3.7 score on a scale
Standard Deviation 6.3
0 score on a scale
Standard Deviation 0
Patient Reported Pain (VAS)
6 weeks - Lower Back
0 score on a scale
Standard Deviation 0
0 score on a scale
Standard Deviation 0
Patient Reported Pain (VAS)
6 weeks - Right Hip
0 score on a scale
Standard Deviation 0
0 score on a scale
Standard Deviation 0
Patient Reported Pain (VAS)
6 weeks - Left Hip
1.7 score on a scale
Standard Deviation 2.9
3.3 score on a scale
Standard Deviation 5.8
Patient Reported Pain (VAS)
6 weeks - Right Knee
2 score on a scale
Standard Deviation 3.5
0 score on a scale
Standard Deviation 0
Patient Reported Pain (VAS)
6 weeks - Right Ankle
0 score on a scale
Standard Deviation 0
3.3 score on a scale
Standard Deviation 5.8
Patient Reported Pain (VAS)
6 weeks - Left Ankle
10.3 score on a scale
Standard Deviation 17.9
0 score on a scale
Standard Deviation 0
Patient Reported Pain (VAS)
6 weeks - Right Foot
0 score on a scale
Standard Deviation 0
4.7 score on a scale
Standard Deviation 8.1
Patient Reported Pain (VAS)
6 weeks - Left Foot
4 score on a scale
Standard Deviation 6.9
0 score on a scale
Standard Deviation 0
Patient Reported Pain (VAS)
12 weeks - Lower Back
0 score on a scale
Standard Deviation 0
0 score on a scale
Standard Deviation 0
Patient Reported Pain (VAS)
12 weeks - Right Hip
0 score on a scale
Standard Deviation 0
0 score on a scale
Standard Deviation 0
Patient Reported Pain (VAS)
12 weeks - Left Hip
0 score on a scale
Standard Deviation 0
0 score on a scale
Standard Deviation 0
Patient Reported Pain (VAS)
12 weeks - Right Knee
0 score on a scale
Standard Deviation 0
0 score on a scale
Standard Deviation 0
Patient Reported Pain (VAS)
12 weeks - Left Knee
0 score on a scale
Standard Deviation 0
0 score on a scale
Standard Deviation 0
Patient Reported Pain (VAS)
12 weeks - Right Ankle
7.7 score on a scale
Standard Deviation 13.3
4.7 score on a scale
Standard Deviation 8.1
Patient Reported Pain (VAS)
12 weeks - Left Ankle
6.7 score on a scale
Standard Deviation 11.5
0 score on a scale
Standard Deviation 0
Patient Reported Pain (VAS)
12 weeks - Right Foot
0 score on a scale
Standard Deviation 0
5.7 score on a scale
Standard Deviation 9.8
Patient Reported Pain (VAS)
12 weeks - Left Foot
2 score on a scale
Standard Deviation 3.5
0 score on a scale
Standard Deviation 0
Patient Reported Pain (VAS)
24 weeks - Lower Back
0 score on a scale
Standard Deviation 0
0 score on a scale
Standard Deviation 0
Patient Reported Pain (VAS)
24 weeks - Right Hip
0 score on a scale
Standard Deviation 0
0 score on a scale
Standard Deviation 0
Patient Reported Pain (VAS)
24 weeks - Left Hip
0 score on a scale
Standard Deviation 0
0 score on a scale
Standard Deviation 0
Patient Reported Pain (VAS)
24 weeks - Right Knee
0 score on a scale
Standard Deviation 0
0 score on a scale
Standard Deviation 0
Patient Reported Pain (VAS)
24 weeks - Left Knee
9.7 score on a scale
Standard Deviation 16.7
0 score on a scale
Standard Deviation 0
Patient Reported Pain (VAS)
24 weeks - Right Ankle
1.3 score on a scale
Standard Deviation 2.3
0 score on a scale
Standard Deviation 0
Patient Reported Pain (VAS)
24 weeks - Left Ankle
4 score on a scale
Standard Deviation 6.9
0 score on a scale
Standard Deviation 0
Patient Reported Pain (VAS)
24 weeks - Right Foot
0 score on a scale
Standard Deviation 0
3.7 score on a scale
Standard Deviation 6.4
Patient Reported Pain (VAS)
24 weeks - Left Foot
0 score on a scale
Standard Deviation 0
0 score on a scale
Standard Deviation 0

PRIMARY outcome

Timeframe: 0-24 weeks

FAAM-ADL (Foot and Ankle Ability Measure - Activities of Daily Living, \[0 -100\]).The FAAM-ADL consists of 21 questions, with a maximum score of 4 per question. The sum of the scores of answered questions is divided by the highest potential score (84 if all 21 questions are answered) and converted to a total score out of 100, with a minimum score of 0. Higher scores indicate better function. Total score range is 0 to 100.

Outcome measures

Outcome measures
Measure
Group I
n=3 Participants
Patients in Group I were assigned to receive a course of CAM walker boot treatment for a period of six weeks.
Group II
n=3 Participants
Patients in Group II were assigned to receive a course of CAM walker boot treatment with an EVENup orthotic shoe lift to be worn on the contralateral foot for a period of six weeks.
Patient Reported Outcome (FAAM-ADL, 0 - 100)
12 weeks
86.1 score on a scale
Standard Deviation 14.8
97.2 score on a scale
Standard Deviation 2.5
Patient Reported Outcome (FAAM-ADL, 0 - 100)
0 weeks
33.7 score on a scale
Standard Deviation 14.1
46.8 score on a scale
Standard Deviation 24.2
Patient Reported Outcome (FAAM-ADL, 0 - 100)
6 weeks
59.9 score on a scale
Standard Deviation 4.8
88.9 score on a scale
Standard Deviation 8.1
Patient Reported Outcome (FAAM-ADL, 0 - 100)
24 weeks
92.9 score on a scale
Standard Deviation 6.2
99.6 score on a scale
Standard Deviation 0.7

Adverse Events

Group I: CAM Walker Boot

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Group II: CAM+EVENup Orthotic Shoe Lift

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Jeremy T. Smith

Brigham and Women's Hospital

Phone: 6177325322

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place